ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 223 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,582,818 | -4.9% | 120,458 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $1,663,767 | -6.3% | 132,045 | -3.0% | 0.00% | -33.3% |
| Q1 2023 | $1,775,766 | -27.8% | 136,074 | -2.4% | 0.00% | -25.0% |
| Q4 2022 | $2,459,457 | +12.9% | 139,425 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $2,178,000 | -0.6% | 142,981 | -3.2% | 0.00% | +33.3% |
| Q2 2022 | $2,191,000 | -38.2% | 147,728 | -6.2% | 0.00% | -40.0% |
| Q1 2022 | $3,547,000 | +12.0% | 157,511 | -8.3% | 0.01% | +25.0% |
| Q4 2021 | $3,167,000 | +29.6% | 171,680 | -6.1% | 0.00% | +33.3% |
| Q3 2021 | $2,443,000 | -31.6% | 182,751 | -5.2% | 0.00% | -25.0% |
| Q2 2021 | $3,570,000 | +0.3% | 192,843 | -18.7% | 0.00% | -20.0% |
| Q1 2021 | $3,560,000 | +3.7% | 237,087 | -0.3% | 0.01% | 0.0% |
| Q4 2020 | $3,434,000 | +71.2% | 237,802 | -3.5% | 0.01% | +66.7% |
| Q3 2020 | $2,006,000 | +20.2% | 246,486 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,669,000 | -3.0% | 246,486 | +0.9% | 0.00% | -25.0% |
| Q1 2020 | $1,721,000 | -29.1% | 244,405 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $2,426,000 | -14.4% | 247,163 | -4.2% | 0.00% | -33.3% |
| Q3 2019 | $2,834,000 | -4.6% | 258,087 | +1.1% | 0.01% | 0.0% |
| Q2 2019 | $2,970,000 | +16.7% | 255,393 | -4.3% | 0.01% | +20.0% |
| Q1 2019 | $2,546,000 | -3.3% | 266,870 | -2.2% | 0.01% | -16.7% |
| Q4 2018 | $2,632,000 | -30.7% | 272,993 | +2.4% | 0.01% | -14.3% |
| Q3 2018 | $3,800,000 | +16.5% | 266,652 | -1.9% | 0.01% | 0.0% |
| Q2 2018 | $3,262,000 | -4.6% | 271,854 | -1.8% | 0.01% | 0.0% |
| Q1 2018 | $3,418,000 | -18.0% | 276,744 | -3.4% | 0.01% | -22.2% |
| Q4 2017 | $4,168,000 | +0.7% | 286,446 | -1.5% | 0.01% | 0.0% |
| Q3 2017 | $4,139,000 | +0.8% | 290,852 | -9.7% | 0.01% | 0.0% |
| Q2 2017 | $4,108,000 | -15.2% | 321,933 | -15.7% | 0.01% | -10.0% |
| Q1 2017 | $4,843,000 | +18.8% | 381,993 | -4.3% | 0.01% | +25.0% |
| Q4 2016 | $4,075,000 | -24.4% | 399,093 | -2.5% | 0.01% | -27.3% |
| Q3 2016 | $5,393,000 | +4.6% | 409,493 | +0.8% | 0.01% | 0.0% |
| Q2 2016 | $5,157,000 | -0.3% | 406,093 | +3.7% | 0.01% | 0.0% |
| Q1 2016 | $5,174,000 | -1.8% | 391,677 | +14.3% | 0.01% | -15.4% |
| Q4 2015 | $5,268,000 | +26.0% | 342,548 | +1.6% | 0.01% | +18.2% |
| Q3 2015 | $4,180,000 | -7.5% | 337,077 | +2.0% | 0.01% | 0.0% |
| Q2 2015 | $4,519,000 | +12.8% | 330,314 | -1.4% | 0.01% | +22.2% |
| Q1 2015 | $4,005,000 | -7.8% | 334,866 | -1.6% | 0.01% | -10.0% |
| Q4 2014 | $4,344,000 | -4.1% | 340,200 | +0.7% | 0.01% | -9.1% |
| Q3 2014 | $4,532,000 | -13.8% | 337,854 | +3.1% | 0.01% | -15.4% |
| Q2 2014 | $5,259,000 | -9.9% | 327,648 | +1.3% | 0.01% | -13.3% |
| Q1 2014 | $5,834,000 | +17.2% | 323,548 | +0.5% | 0.02% | +15.4% |
| Q4 2013 | $4,977,000 | +4.7% | 321,948 | +0.7% | 0.01% | -7.1% |
| Q3 2013 | $4,755,000 | +18.6% | 319,748 | +3.2% | 0.01% | +7.7% |
| Q2 2013 | $4,010,000 | -1.0% | 309,893 | +4.0% | 0.01% | -7.1% |
| Q1 2013 | $4,049,000 | – | 297,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |